Asia-Pacific Drug Delivery Market, By Product Type (Oral Drug Delivery, Pulmonary Drug Delivery, Injectable Drug Delivery, Opthalmic Drug Delivery, Nasal Drug Delivery, Topical Drug Delivery, Implantable Drug Delivery, Transmucosal Drug Delivery), End User (Hospitals, Community Healthcare, Home Healthcare, Clinics, Others), Distribution Channel (Hospital Pharmacies, Pharmacy Stores, Direct Tenders, Online Pharmacy), Country (Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific)-Industry Trends and Forecast to 2029
The drug delivery market is expected to witness market growth at a rate of 12.9% in the forecast period of 2022 to 2029. Data Bridge Market Research report on drug delivery market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rise in the demand for effective delivery technique in the biopharmaceuticals is escalating the growth of drug delivery market.
The process of introducing a therapeutic effect in the body of human by administering a drug at a specific targeted site is known as drug delivery. By controlling the rate, time and release of drug in the body the safety and efficacy of drug can be improved.
Major factors that are expected to boost the growth of the drug delivery market in the forecast period rise in the cases and presence of chronic diseases and enhancement in the safety. Furthermore, the ability of a drug to control the drug release in the body is further anticipated to propel the growth of the drug delivery market. Moreover, the technological advancement is further estimated to cushion the growth of the drug delivery market. On the other hand, the growing cost of drug delivery procedures is further projected to impede the growth of the drug delivery market in the timeline period.
In addition, the inflexible regulations for drug delivery procedures will further provide potential opportunities for the growth of the drug delivery market in the coming years. However, the launch of developed new products and development in technologies might further challenge the growth of the drug delivery market in the near future.
This drug delivery market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the drug delivery market, contact Data Bridge Market Research for an Analyst Brief. Our team will help you take an informed market decision to achieve market growth.
Asia-Pacific Drug Delivery Market Scope and Market Size
The drug delivery market is segmented on the basis of product type, end user and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them in making strategic decisions for the identification of core market applications.
- On the basis of product type, the drug delivery market is segmented into oral drug delivery, pulmonary drug delivery, injectable drug delivery, opthalmic drug delivery, nasal drug delivery, topical drug delivery, implantable drug delivery and transmucosal drug delivery. oral drug delivery, pulmonary drug delivery, injectable drug delivery, ocular drug delivery, nasal drug delivery, topical drug delivery implantable drug delivery and transmucosal drug delivery. The oral drug delivery is segmented into solid oral drugs, liquid oral drugs and semi-solid oral drugs. The solid oral drugs are sub-segmented into tablets, capsules, powders and pills. The liquid oral drugs are sub-segmented into solutions and syrups. The semi-solid oral drugs are further sub-segmented into gels, emulsions and elixirs. The pulmonary drug delivery is segmented into formulations and devices. The devices are further sub-segmented into metered dose inhalers, dry powder inhalers and nebulizers. The nebulizers are sub-segmented into jet nebulizers, ultrasonic nebulizers and soft mist nebulizers. The injectable drug delivery is segmented into devices, self-injection devices and other injector devices. The conventional injection devices are sub-segmented into material, glass, plastic, product and usability. The product is segmented into fillable syringes and prefilled syringes. The usability is segmented into reusable syringes and disposable syringes. The self-injection devices are sub-segmented into needle-free injectors, auto injectors, pen injectors and wearable injectors. The formulations are divided into conventional drug delivery, novel drug delivery formulations and long-acting injection formulations. The ocular drug delivery is sub-segmented into formulations and ocular devices. The formulations are further sub-divided into liquid formulations and semi-solid formulations. The liquid formulations are divided into eye drops and liquid sprays. The semi-solid formulations consist of gels and eye ointments. The ocular devices consist of drug-coated contact lenses and ocular inserts. The nasal drug delivery is sub-segmented into nasal drops, nasal sprays, nasal powders and nasal gels. Under topical drug delivery it is segmented into formulations and devices (transdermal drug delivery). The formulations liquid is sub-segmented into topical drug delivery, semi-solid topical drug delivery and solid topical drug delivery. The liquid topical drug delivery is again sub-segmented into solutions and suspensions. The semi-solid topical drug delivery is sub-segmented into creams, gels, ointments, pastes and lotions. The solid topical drug delivery is segmented into suppositories and powders. The devices are sub-segmented into transdermal patches and transdermal gels. Implantable drug delivery is sub-segmented into active implantable drug delivery and passive implantable drug delivery. The transmucosal drug delivery is sub-segmented into oral transmucosal drug delivery and other transmucosal drug delivery. The oral transmucosal drug delivery is further sub-segmented into buccal drug delivery and sublingual drug delivery whereas the other transmucosal drug delivery is further sub-segmented into rectal transmucosal drug delivery and vaginal transmucosal drug delivery.
- On the basis of end user, the drug delivery market is segmented into hospitals, community healthcare, home healthcare, clinics and others.
- On the basis of distribution channel, the drug delivery market is segmented into hospital pharmacies, pharmacy stores, direct tenders and online pharmacy.
Drug Delivery Market Country Level Analysis
The drug delivery market is analyzed, and market size insights and trends are provided by country, product type, end user and distribution channel as referenced above.
The countries covered in the drug delivery market report are the China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC).
China is projected to observe significant amount of growth in the drug delivery market due to the rise in the funds assigned by the top companies in the field of research and development activities. Moreover, the decrease in the prices of labour and clinical trials is further anticipated to propel the growth of the drug delivery market in the coming years.
The country section of the drug delivery market report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as consumption volumes, production sites, and volumes, import-export analysis, price trend analysis, cost of raw materials, downstream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The drug delivery market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the drug delivery market, the impact of technology using lifeline curves, and changes in healthcare regulatory scenarios and their impact on the drug delivery market. The data is available for the historic period 2010-2020.
Competitive Landscape and Drug Delivery Market Share Analysis
The drug delivery market competitive landscape provides details by a competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to the drug delivery market.
Some of the major players operating in the drug delivery market are Johnson & Johnson Services, Inc., F. Hoffmann-La Roche Ltd, Merck Sharp & Dohme Corp., Bayer AG, Pfizer Inc, Novartis AG, 3M, BD, GlaxoSmithKline Plc, Sanofi among others.
Customization Available : Asia-Pacific Drug Delivery Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market, and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.